Alnylam Pharmaceuticals is one of the most important rare disease biotechnology companies because it validated RNA interference as a therapeutic modality and built approved medicines for genetically or biologically defined diseases. Its platform is especially relevant to rare diseases where silencing a disease-causing gene can produce meaningful clinical benefit.

Almac Group is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Allogene Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier II Cell & Gene Therapy Developers 1 ranking category Overview

Ajinomoto Bio-Pharma Services is a CDMO providing development and manufacturing services across small molecule APIs, drug product, sterile manufacturing, high-potency compounds, and antibody-drug conjugates. The company operates as part of Ajinomoto Group and serves pharmaceutical and biotechnology sponsors globally.

Alkermes is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

AGC Biologics is a global biopharmaceutical CDMO providing development and manufacturing services across biologics and advanced modalities. Its services include protein expression biologics, plasmid DNA, mRNA, viral vectors, and genetically engineered cells.

Advanced Clinical is a clinical development services provider supporting pharmaceutical, biotechnology, and medical device sponsors through CRO services, functional service provider models, clinical staffing, biometrics, and trial execution support.

Adaptimmune Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview

Acadia Pharmaceuticals is a specialist developer in neurological and neuropsychiatric disorders, with relevance to rare disease through Rett syndrome and related central nervous system conditions. The company’s focus on serious neurological disorders gives it a differentiated position in orphan and specialty medicine.

AbbVie remains one of the world’s most important specialty pharmaceutical companies. Although it operates at large pharmaceutical scale, its business model is deeply aligned with specialty medicine, particularly immunology, hematologic oncology, neuroscience, and medical aesthetics.

Praxis Precision Medicines is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Polpharma Biologics is a specialist biologics development and manufacturing organization with capabilities in biosimilars, mammalian cell culture, process development, analytical services, and biologics manufacturing. The company has built a strong European biologics platform with relevance in both proprietary biosimilars and contract manufacturing.

Piramal Pharma Solutions is an integrated CDMO providing services across drug discovery support, process development, API manufacturing, drug product development, sterile manufacturing, high-potency APIs, and antibody-drug conjugates. The company serves global pharmaceutical and biotechnology sponsors through a multi-site international network.

Pharmaron is a major China-based contract research and development organization with a broad platform spanning discovery, preclinical research, clinical development, manufacturing-related services, and laboratory support. It represents one of the most important Asia-origin CRO and CRDMO platforms.

Pfizer remains one of the most important vaccine developers globally, with major franchises in pneumococcal disease, RSV, COVID-19, and other infectious disease categories. Its partnership with BioNTech established Pfizer as a central player in mRNA vaccine commercialization and demonstrated its ability to rapidly scale global vaccine supply.

PCI Pharma Services is a major CDMO and pharmaceutical services provider focused on clinical trial supply, commercial packaging, sterile fill-finish, high-potency manufacturing support, and drug-device combination product services. The company plays a particularly important role in the later stages of pharmaceutical product development and commercialization.

Parexel is one of the most established global CROs, with long-standing capabilities across clinical trial management, regulatory affairs, biostatistics, medical writing, pharmacovigilance, market access, real-world evidence, and patient-centered development. The company has served pharmaceutical and biotechnology sponsors for decades and remains one of the most recognized names in outsourced clinical development.

Pacira BioSciences is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

Otsuka Pharmaceutical is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Orchard Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview